BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kennel PJ, Kneifati-Hayek J, Bryan J, Banerjee S, Sobol I, Lachs MS, Safford MM, Goyal P. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES). BMC Cardiovasc Disord 2019;19:76. [PMID: 30935411 DOI: 10.1186/s12872-019-1058-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Goyal P, Zainul O, Marshall D, Kitzman DW. Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.06.006] [Reference Citation Analysis]
2 Duangsong J, Samansaplert P, Khamkong Y, Jenghua K. Use of potentially inappropriate medications for heart failure according to the three sets of heart failure-specific criteria in Thai older patients with heart failure. J Geriatr Cardiol 2022;19:498-510. [PMID: 35975013 DOI: 10.11909/j.issn.1671-5411.2022.07.001] [Reference Citation Analysis]
3 Ishida T, Yamaoka K, Suzuki A, Nakata Y. Effectiveness of polypharmacy reduction policy in Japan: nationwide retrospective observational study. Int J Clin Pharm 2021. [PMID: 34748135 DOI: 10.1007/s11096-021-01347-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Minamisawa M, Claggett B, Suzuki K, Hegde SM, Shah AM, Desai AS, Lewis EF, Shah SJ, Sweitzer NK, Fang JC, Anand IS, O'Meara E, Rouleau JL, Pitt B, Pfeffer MA, Solomon SD, Vardeny O. Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 2021;14:e008293. [PMID: 34674539 DOI: 10.1161/CIRCHEARTFAILURE.120.008293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Arunmanakul P, Chaiyakunapruk N, Phrommintikul A, Ruengorn C, Permsuwan U. Cost-effectiveness analysis of pharmacist interventions in patients with heart failure in Thailand. J Am Pharm Assoc (2003) 2021:S1544-3191(21)00423-4. [PMID: 34756525 DOI: 10.1016/j.japh.2021.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kang J, Moser DK, Biddle MJ, Oh G, Lennie TA. Age- and sex-matched comparison of diet quality in patients with heart failure to similarly aged healthy older adults. J Nutr Sci 2021;10:e65. [PMID: 34527223 DOI: 10.1017/jns.2021.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev 2021. [PMID: 34213753 DOI: 10.1007/s10741-021-10135-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Arunmanakul P, Kengkla K, Chaiyasothi T, Phrommintikul A, Ruengorn C, Permsuwan U, Thakkinstian A, Page RL, Munger MA, Nathisuwan S, Chaiyakunapruk N. Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta‐analysis. J Am Coll Clin Pharm 2021;4:871-82. [DOI: 10.1002/jac5.1442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Brinker LM, Konerman MC, Navid P, Dorsch MP, McNamara J, Willer CJ, Tinetti ME, Hummel SL, Goyal P. Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction. Am J Med 2021;134:374-82. [PMID: 32822663 DOI: 10.1016/j.amjmed.2020.07.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
10 Wensink MJ, Rizzi S, Jensen TK, Skakkebaek NE, Lu Y, Lindahl-Jacobsen R, Eisenberg ML. Paternal prescription medication before conception: A retrospective cohort study of all births in Denmark 1997-2017. Scand J Public Health 2021;:1403494820987468. [PMID: 33615897 DOI: 10.1177/1403494820987468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wu Y, Zhu W, He X, Xue R, Liang W, Wei F, Wu Z, Zhou Y, Wu D, He J, Dong Y, Liu C. Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial. Br J Gen Pract 2021;71:e62-70. [PMID: 33257457 DOI: 10.3399/bjgp21X714245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jenghua K. Prevalence and associated factors of potentially inappropriate medications among Thai patients with heart failure. Int J Clin Pract 2021;75:e13878. [PMID: 33259674 DOI: 10.1111/ijcp.13878] [Reference Citation Analysis]
13 Unlu O, Levitan EB, Reshetnyak E, Kneifati-Hayek J, Diaz I, Archambault A, Chen L, Hanlon JT, Maurer MS, Safford MM, Lachs MS, Goyal P. Polypharmacy in Older Adults Hospitalized for Heart Failure. Circ Heart Fail 2020;13:e006977. [PMID: 33045844 DOI: 10.1161/CIRCHEARTFAILURE.120.006977] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 21.0] [Reference Citation Analysis]
14 Chen N, Alam AB, Lutsey PL, MacLehose RF, Claxton JS, Chen LY, Chamberlain AM, Alonso A. Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation. J Am Heart Assoc 2020;9:e015089. [PMID: 32448024 DOI: 10.1161/JAHA.119.015089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
15 Sirois C, Lunghi C, Berthelot W, Laroche ML, Frini A. Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study. Int J Clin Pharm 2020;42:40-50. [PMID: 31721038 DOI: 10.1007/s11096-019-00935-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 34] [Article Influence: 0.7] [Reference Citation Analysis]
16 Goyal P, Kneifati-Hayek J, Archambault A, Mehta K, Levitan EB, Chen L, Diaz I, Hollenberg J, Hanlon JT, Lachs MS, Maurer MS, Safford MM. Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization. JACC Heart Fail 2020;8:25-34. [PMID: 31706836 DOI: 10.1016/j.jchf.2019.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]